Vasculonecrotic Erythema Nodosum Leprosum in a Case of Lepromatous Leprosy: A Rare and Severe Presentation

Authors

  • Varisa Ramkul Institute of Dermatology, Department of Medical Services, Ministry of Public Health, Bangkok, Thailand.
  • Phatcharawat Chirasuthat Institute of Dermatology, Department of Medical Services, Ministry of Public Health, Bangkok, Thailand.

Keywords:

Leprosy, Erythema nodosum leprosum, Lepra reaction, Vasculonecrotic phenomenon

Abstract

Lepromatous leprosy, caused by Mycobacterium leprae or Mycobacterium lepromatosis, is a progressive, multi-systemic infection affecting the skin and peripheral nerves. Erythema nodosum leprosum (ENL) is a severe immunological complication in lepromatous and borderline leprosy, presenting with inflamed skin nodules. Vasculonecrotic ENL, a rare form, involves deep ulcerations, necrosis, and systemic effects. We report a 40-year-old Myanmarese male with multibacillary leprosy presenting with erythematous patches, nodules, and vesiculopustular bullous eruptions on the trunk and extremities, with bilateral median nerve enlargement and sensory loss. Histopathology confirmed lepromatous leprosy with necrotizing vasculitis and neutrophil infiltration, leading to a diagnosis of vasculonecrotic ENL. Despite initial improvement with multidrug therapy and oral corticosteroids, the patient experienced a relapse of bullous lesions and neuritis following prednisolone tapering. Treatment was intensified with high-dose corticosteroids, leading to the resolution of his bullous lesions.

References

Gilmore A, Roller J, Dyer JA. Leprosy (Hansen's disease): An Update and Review. Mo Med 2023;120:39-44.

Alrehaili J. Leprosy Classification, Clinical Features, Epidemiology, and Host Immunological Responses: Failure of Eradication in 2023. Cureus 2023;15:e45987.

Dewi DAR, Djatmiko CBP, Rachmawati I, Arkania N, Wiliantari NM, Nadhira F. Immunopathogenesis of Type 1 and Type 2 Leprosy Reaction: An Update Review. Cureus 2023;15:e47421.

Agarwal US, Mehta S, Kumar R, Besarwal RK, Agarwal P. Bullous lesions in leprosy: A rare phenomenon. Indian J Dermatol Venereol Leprol. 2013;79:107–9.

Alakad R, Nofal A, Assaf M. Atypical presentations of erythema nodosum leprosum: Diagnostic and therapeutic aspects. J Dtsch Dermatol Ges 2021;19:1133-43.

Vashisht D, Das AL. Bullous erythema nodosum leprosum. Med J Armed Forces India 2013;69:71-3.

Sittisaksomjai S, Pongcharoen P, Wimoolchart S. A Rheumatoid Arthritis-Like Presentation in Multibacillary Leprosy with Concurrent Erythema Nodosum Leprosum. Thai J Dermatol. 2024;40:108-13.

Maulida M, Vella V, Budini SS, et al. Systemic manifestation of necrotic erythema nodosum leprosum: A case report of a fatal leprosy. Narra J 2023;3:e216.

Fogagnolo L, Souza EM, Cintra ML, Velho PE. Vasculonecrotic reactions in leprosy. Braz J Infect Dis 2007;11:378-82.

Serrano-Coll H, Wan EL, Restrepo-Rivera L, Cardona-Castro N. Leprosy reactions: Unraveling immunological mechanisms underlying tissue damage in leprosy patients. Pathog Dis 2024;82:ftae013.

World Health Organization. Leprosy/Hansen Disease: Management of Reactions and Prevention of Disabilities. Medical management of reactions and neuritis in leprosy. Geneva: WHO 2020:p17-25.

Djawad K. Pentoxifylline therapy for patients with type 2 leprosy reactions: erythema nodosum leprosum in steroid-dependent cases. Vestn Dermatol Venerol 2021;97:46-53.

Bhat RM, Vaidya TP. What is New in the Pathogenesis and Management of Erythema Nodosum Leprosum. Indian Dermatol Online J 2020;11:482-92.

Walker SL, Lebas E, Doni SN, Lockwood DNJ, Lambert SM. The mortality associated with erythema nodosum leprosum in Ethiopia: A retrospective hospital-based study. PLoS Negl Trop Dis 2014;8:e2690.

Downloads

Published

2025-11-06

How to Cite

Ramkul, V., & Chirasuthat, P. . (2025). Vasculonecrotic Erythema Nodosum Leprosum in a Case of Lepromatous Leprosy: A Rare and Severe Presentation. Thai Journal of Dermatology, 41(4), 106–110. retrieved from https://he02.tci-thaijo.org/index.php/TJD/article/view/272491